Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > Gross Profit

Amag Pharmaceuticals Gross Profit Chart (AMAG)

Amag Pharmaceuticals annual/quarterly Gross Profit from 2010 to 2020. Gross profit is the profit after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Gross profit = Revenue - Cost of Goods Sold.
  • Amag Pharmaceuticals Gross Profit for the quarter ending June 06, 2020 was $26m a -101.19% decrease of -27m year over year
  • Amag Pharmaceuticals Gross Profit for the last 12 months ending June 06, 2020 was $158m a -19.06% decrease of -30m year over year
  • Amag Pharmaceuticals Annual Gross Profit for 2019 was $179m a -28.68% decrease of -51m from 2018
  • Amag Pharmaceuticals Annual Gross Profit for 2018 was $230m a -12.68% decrease of -29m from 2017
  • Amag Pharmaceuticals Annual Gross Profit for 2017 was $259m a -10.25% decrease of -27m from 2016
Other Income Statement Metrics:
  • Amag Pharmaceuticals EBITDA for the quarter ending December 12, 2018 was $0m a -35,031.33% decrease of -29m year over year
  • Amag Pharmaceuticals Net Income for the quarter ending December 12, 2018 was $-22m a -143.49% increase of 32m year over year
  • Amag Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $122m a -29.53% decrease of -36m year over year
View Chart On Koyfin

Quarterly AMAG Gross Profit Data

06/2020$26m
03/2020$36m
12/2019$33m
09/2019$53m
06/2019$43m
03/2019$45m
12/2018$53m
09/2018$70m
06/2018$58m
03/2018$47m

Annual AMAG Gross Profit Data

2019$179m
2018$230m
2017$259m
2016$286m
2015$301m
2014$92m
2013$60m
2012$54m
2011$10m
2010$23m